Biliary Tract Cancers (BTCs) Market is segmented By Treatment (Chemotherapy (Platinum-based Agents, ...
Market Size in USD Bn
CAGR5.7%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 5.7% |
Market Concentration | Medium |
Major Players | Roche Holding AG, Merck & Co., Inc., AstraZeneca plc, Bristol Myers Squibb Company, Novartis AG and Among Others |
The biliary tract cancers (BTCs) market is estimated to be valued at USD 0.87 billion in 2025 and is expected to reach USD 1.28 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2032. The increasing prevalence of biliary tract cancers such as gallbladder and bile duct cancers due to changing lifestyle patterns and rising geriatric population is driving the growth of this market.